Koers Respirerx Pharmaceuticals Inc OTC Bulletin Board
Aandelen
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 289K 270K |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -3 mln. -2,8 mln. | Nettowinst (verlies) 2022 | -2 mln. -1,87 mln. | EV/omzet 2021 | - |
Nettoschuld 2021 | 2,08 mln. 1,94 mln. | Nettoschuld 2022 | 2,71 mln. 2,53 mln. | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-0,29
x | K/w-verhouding 2022 |
-0,06
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 93,37% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22-03-13 |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22-03-13 |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 15-10-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22-03-13 |
Director/Board Member | - | 22-03-23 | |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22-03-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,15% | 124 mld. | |
+18,02% | 112 mld. | |
+5,07% | 22,94 mld. | |
-12,75% | 22,22 mld. | |
-9,86% | 17,02 mld. | |
-14,97% | 16,88 mld. | |
-39,94% | 16,87 mld. | |
+2,80% | 13,63 mld. | |
+27,39% | 11,61 mld. |
- Beurs
- Aandelen
- Koers RSPI
- Koers